Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis- related graft failure and disseminated bacillus Calmette-Guérin infection

Documenti analoghi

• Alterations in the brain adenosine metabolism cause behavioral and neurological impairment in ADA-deficient mice and patients
  di: Sauer, Aisha V., et al.
  Pubblicazione: (2017)
• First Occurrence of Plasmablastic Lymphoma in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Disease Patient and Review of the Literature
  di: Migliavacca, Maddalena, et al.
  Pubblicazione: (2018)
• Use of Defibrotide to help prevent post-transplant endothelial injury in a genetically predisposed infant with metachromatic leukodystrophy undergoing hematopoietic stem cell gene therapy
  di: Calbi, Valeria, et al.
  Pubblicazione: (2018)
• Bone marrow harvesting from paediatric patients undergoing haematopoietic stem cell gene therapy
  di: Tucci, Francesca, et al.
  Pubblicazione: (2019)
• Role of reduced intensity conditioning in T-cell and B-cell immune reconstitution after HLA-identical bone marrow transplantation in ADA-SCID
  di: Cancrini, Caterina, et al.
  Pubblicazione: (2010)